Achieving Canadian Treat-to-Target Criteria in Moderate-to-Severe Atopic Dermatitis: A Retrospective Analysis of Outcomes from Real-World Canadian Practice - Top-Institutions - MDSpire

Achieving Canadian Treat-to-Target Criteria in Moderate-to-Severe Atopic Dermatitis: A Retrospective Analysis of Outcomes from Real-World Canadian Practice

  • By

  • Jensen Yeung

  • Parbeer Grewal

  • Mark Legault

  • Jason Stacey

  • Irina Turchin

  • June 20, 2026

  • 0 min

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    McGill University Health Centre (MUHC)
    McGill University Health Centre (MUHC)

    Montréal, Québec

    Key Differentiators

    • Atopic Dermatitis
    • Dermatology

  • #2

    University of British Columbia (UBC)
    University of British Columbia (UBC)

    Vancouver, British Columbia

    Key Differentiators

    • Dermatology
    • Clinical Trials

Original Source(s)

Achieving Canadian Treat-to-Target Criteria in Moderate-to-Severe Atopic Dermatitis: A Retrospective Analysis of Outcomes from Real-World Canadian Practice

  • by Jensen Yeung, Parbeer Grewal, Mark Legault, Jason Stacey, Irina Turchin

  • June 20, 2026

Related Content

Autohemotherapy combined with other external treatments of Traditional Chinese Medicine for chronic urticaria: a systematic review and meta-analysis

Psoriasis–AD Switching May Mimic Treatment Failure

Recognizing sustained switches between the two diseases can prevent premature discontinuation of effective biologics and point toward Janus kinase inhibitors, a 148-patient cohort suggests.

Is dry skin a clue to diabetic retinopathy? Clinical insights from the overall dry skin score